← Back to Search

Xanthine Oxidase Inhibitor

dotinurad 4mg for Gout

Phase 1 & 2

Recruiting

Research Sponsored by Urica Therapeutics Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Awards & highlights

Study Summary

This trial tests a new drug's effects on gout, and its interactions with other drugs to reduce uric acid levels and excretion.

Eligible Conditions

Gout
High Uric Acid

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Area under the plasma concentration versus time curve (AUC)

Peak plasma concentrations (Cmax)

Terminal half life (T1/2)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: dotinurad 4mgExperimental Treatment3 Interventions

dotinurad 4mg q.d.

Group II: dotinurad 2mgExperimental Treatment3 Interventions

dotinurad 2mg q.d.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

allopurinol

2005

Completed Phase 4

~1020

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Urica Therapeutics Inc.Lead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly people being included in this research initiative?

"Eligible participants must be between 18 and 75 years old to partake in this medical trial."

Answered by AI

Am I eligible to join this medical experiment?

"Eligibility for this medical trial requires prospective participants to have gout and be between 18 and 75 years old. In total, the study is looking to recruit 20 individuals."

Answered by AI

Are there still openings for participation in this medical experiment?

"Right, the information on clinicaltrials.gov supports that this research is open for enrollment. It was originally posted on October 1st 2023 and has been recently updated as of September 20th 2023. The trial requires a total of twenty participants to be recruited at four different locations."

Answered by AI

How many locations are currently conducting this research trial?

"At this time, enrolment is available at 4 clinical sites: Miami Lakes, Mesquite and San Antonio as well as a fourth. To reduce the need for transit between medical centres, it's important to select the one closest to you."

Answered by AI

How many individuals have chosen to participate in this trial thus far?

"Correct. The records hosted on clinicaltrials.gov indicate that this medical study, which was first posted on October 1st 2023, is actively seeking participants. Approximately 20 individuals need to be sourced from 4 different research facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia

2023. "Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06056570.

All > Gout